The North America RSV Diagnostics Market was valued at USD 585 Million in 2025 and is projected to reach USD 1,233 Million by 2035, expanding at a CAGR of 6.9% during the forecast period of 2024 to 2035. The market growth is driven by rising RSV cases, technological advancements in diagnostics, and increased awareness regarding early detection, promoting the adoption of molecular diagnostic techniques in the region.
The economic impact of tariffs on "North America RSV Diagnostics Market".
North America RSV Diagnostics Market Growth Drivers
One of the primary drivers in the North America RSV Diagnostics market is the increasing incidence of respiratory syncytial virus (RSV) infections among infants, elderly patients, and immunocompromised individuals. According to Becton, Dickinson and Company (BD), the rising hospitalization rates due to severe RSV have compelled healthcare authorities to promote the implementation of diagnostic tools that facilitate early and accurate detection. This has resulted in a surge in demand for point-of-care and laboratory-based diagnostic solutions capable of delivering quick and precise results.
Technological advancements are catalyzing market growth significantly. Recent innovations by Abbott Laboratories, for example, have improved molecular diagnostic tests with enhanced sensitivity and specificity. Their RSV molecular assays reduce turnaround times and minimize false negatives, thereby improving patient management and clinical outcomes. Such advancements are propelling healthcare institutions across North America to upgrade their diagnostic infrastructures, further fueling market expansion.
North America RSV Diagnostics Market Trends
A notable trend shaping the market is the growing adoption of rapid molecular diagnostic platforms. Companies like QuidelOrtho Corporation have introduced user-friendly, multiplexed RSV testing kits that allow simultaneous detection of multiple respiratory pathogens. This shift towards rapid, multiplexed testing is streamlining clinical workflows, especially during the RSV season when distinguishing between RSV and other respiratory infections is essential.
Another emerging trend is the expansion of telemedicine integrated with home-based RSV diagnostic solutions. Innovators like bioMérieux are developing at-home test kits connected with digital platforms, enabling remote patient monitoring and timely care. Such integrations leverage the convenience of home testing and the reliability of professional diagnostics, meeting the demand for accessible and scalable solutions.
North America RSV Diagnostics Market Opportunities
There is significant opportunity for market players to provide affordable, easy-to-use RSV diagnostic kits targeting rural and underserved communities. Companies like Cepheid can tap into this segment by expanding their distribution channels and educational initiatives, enhancing market penetration.
Another opportunity lies in collaborating with public health agencies to develop large-scale screening programs during peak RSV seasons. Such partnerships, exemplified by Thermo Fisher Scientific, can boost market reach and strengthen brand presence, while contributing to population-wide RSV management efforts.
North America RSV Diagnostics Market Revenue (USD Million), 2020-2035
The market revenue chart demonstrates a robust growth trajectory for the North America RSV Diagnostics Market from 2020 to 2035. Starting at USD 355 Million in 2020, the market exhibits steady expansion year over year, reflecting increasing demand for advanced RSV diagnostic tools and broader adoption across healthcare settings. By mid-decade, revenues surpass USD 500 Million, with acceleration observed post-2025 due to regulatory approvals and new product launches. By 2035, the market is expected to more than double compared to 2025, reaching USD 1,233 Million. This growth is supported by technological innovation, the rising prevalence of RSV, and heightened awareness of early diagnostics, ensuring a dynamic and expanding landscape.
North America RSV Diagnostics Market Share by Region, 2025
The pie chart for the North America RSV Diagnostics Market in 2025 reveals that the United States dominates with a 75% market share, driven by high healthcare expenditure and adoption of advanced diagnostic techniques. Canada holds a 17% share, supported by government-led RSV awareness initiatives and widespread availability of diagnostic tools. Mexico constitutes 6% of the market, reflecting its emerging healthcare ecosystem and gradual uptick in RSV testing. The 'Rest of North America,' including Caribbean nations and territories, accounts for 2% share, indicating potential for future growth as awareness and healthcare access improve. Overall, the regional segmentation underscores the market's concentration in developed economies, with substantial expansion opportunities in less-penetrated areas.
North America RSV Diagnostics Market Recent Developments
In May 2024, Abbott Laboratories received FDA clearance for its advanced RSV and Influenza A/B multiplex assay for use on the Alinity m molecular diagnostics system. This approval enhances hospitals' and clinical labs’ capability to identify RSV and distinguish it from other viral infections, thus improving patient management, especially during the RSV peak season.
In June 2024, QuidelOrtho Corporation announced the launch of its Sofia® 2 SARS Antigen+RSV FIA, a next-generation rapid testing solution for simultaneous SARS-CoV-2 and RSV detection at the point of care. This product launch allows healthcare providers to quickly differentiate between common respiratory viruses using a single specimen, raising diagnostic efficiency during flu and RSV seasons.
In April 2024, bioMérieux partnered with a major North American telemedicine provider to pilot connected at-home RSV antigen testing kits. This initiative integrates remote diagnostics with digital consultation, providing patients with rapid, actionable results and seamless access to clinical advice. The collaboration marks a step forward in improving access to RSV testing and care delivery in the region.
Press Releases